Legend Biotech Corporation (LEGN) is listed on NASDAQ in Pharmaceutical Stocks. It is $19.88, -3.02%. RSI is 38.9, near oversold. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 38.9 Near Oversold
Volume 698.2K
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Casey Patrick John | Insider | Sell | 6,000 | $14.80 | $88,800 | 2026 Jun 30 |
| Huang Ying | Chief Executive Officer | Sell | 5,566 | $14.78 | $82,265 | 2026 Jun 25 |
| Huang Ying | Chief Executive Officer | Sell | 9,936 | $8.77 | $87,139 | 2026 Mar 25 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
Take LEGN further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put LEGN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Legend Biotech Corporation next reports.
Set alerts on LEGN
Get notified when Legend Biotech Corporation hits your price targets or technical conditions are met.
Get Started Free